Kayo Shimada

Molecular epidemiology of multidrug-resistant Acinetobacter baumannii isolates in a university hospital in Nepal reveals the emergence of a novel epidemic clonal lineage

Shovita Shrestha, Tatsuya Tada, Tohru Miyoshi‐Akiyama et al. · International Journal of Antimicrobial Agents · 2015 · 73 citations

Life Sciences, Infectious Diseases, Microbiology +17

Rapid detection of Pseudomonas aeruginosa in mouse feces by colorimetric loop-mediated isothermal amplification

Motoki Goto, Kayo Shimada, Ayako Sato et al. · Journal of Microbiological Methods · 2010 · 60 citations

Life Sciences, Infectious Diseases, Microbiology +15

Dissemination of 16S rRNA Methylase ArmA-Producing Acinetobacter baumannii and Emergence of OXA-72 Carbapenemase Coproducers in Japan

Tatsuya Tada, Tohru Miyoshi‐Akiyama, Kayo Shimada et al. · Antimicrobial Agents and Chemotherapy · 2014 · 59 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Dissemination of Carbapenem-resistant Klebsiella pneumoniae clinical isolates with various combinations of Carbapenemases (KPC-2, NDM-1, NDM-4, and OXA-48) and 16S rRNA Methylases (RmtB and RmtC) in Vietnam

Tatsuya Tada, Mitsuhiro Tsuchiya, Kayo Shimada et al. · BMC Infectious Diseases · 2017 · 54 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

A Modified Carbapenem Inactivation Method, CIMTris, for Carbapenemase Production in Acinetobacter and Pseudomonas Species

Kohei Uechi, Tatsuya Tada, Kayo Shimada et al. · Journal of Clinical Microbiology · 2017 · 54 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +10